Essential Partners’s Day One Biopharmaceuticals DAWN Stock Holding History

Essential Partners’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-431	Closed	-$9.24K	–	2877
2026 Q1	$9.24K	Buy	431 +143	+50%	+$2.02K	﹤0.01%	1296
2025 Q4	$2.68K	Buy	288 +29	+11%	+$242	﹤0.01%	1700
2025 Q3	$1.83K	Buy	+259	New	+$1.78K	﹤0.01%	1823

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Essential Partners's DAWN Position: Q2 2026 in Review

Essential Partners sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 431 shares — an estimated $9.24K sold.

Essential Partners first reported a position in DAWN in Q3 2025 and held it in 3 quarters. The position peaked at $9.24K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Essential Partners reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Essential Partners sold 431 Day One Biopharmaceuticals shares in Q2 2026, an estimated $9.24K.
Essential Partners first reported a position in Day One Biopharmaceuticals in Q3 2025 and held it in 3 quarters.
Essential Partners's Day One Biopharmaceuticals position peaked at $9.24K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.